Shandong Weigao Group Medical Polymer Co (HK:1066) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shandong Weigao Group Medical Polymer Co. reported a decrease in unaudited revenue by 3.8% and net profit by 7.5% for the first half of 2024 compared to the same period in the previous year. Despite the downturn, the company has proposed an increased interim dividend of RMB0.0919 per share, up from RMB0.0734 per share in 2023, pending shareholder approval.
For further insights into HK:1066 stock, check out TipRanks’ Stock Analysis page.